{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T05:03:45Z","timestamp":1733029425040,"version":"3.30.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,29]]},"DOI":"10.7759\/cureus.74790","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T04:15:41Z","timestamp":1732940141000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Efficacy of Beractant (SURVANTA\u00ae) and Poractant Alfa (CUROSURF\u00ae) in Preterm Infants With Respiratory Distress Syndrome in Tawam Hospital, Al Ain, UAE: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Fahad","family":"Butt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Abusallout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Zaineh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feryal","family":"El khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Hamwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Alabdullatif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000448985","article-title":"European consensus guidelines on the management of respiratory distress syndrome\u20142016 update","volume":"111","author":"Sweet DG","year":"2017","unstructured":"Sweet DG, Carnielli V, Greisen G, et al.. European consensus guidelines on the management of respiratory distress syndrome\u20142016 update. Neonatology. 2017, 111:107-25. 10.1159\/000448985","journal-title":"Neonatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1542\/pir.35-10-417","article-title":"Respiratory distress in the newborn","volume":"35","author":"Reuter S","year":"2014","unstructured":"Reuter S, Moser C, Baack M. Respiratory distress in the newborn. Pediatr Rev. 2014, 35:417-28. 10.1542\/pir.35-10-417","journal-title":"Pediatr Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14767050410001668266","article-title":"Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome","volume":"15","author":"Hammoud M","year":"2004","unstructured":"Hammoud M, Al-Kazmi N, Alshemmiri M, Thalib L, Ranjani VT, Devarajan LV, Elsori H. Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome. J Matern Fetal Neonatal Med. 2004, 15:167-75. 10.1080\/14767050410001668266","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000528914","article-title":"European consensus guidelines on the management of respiratory distress syndrome: 2022 update","volume":"120","author":"Sweet DG","year":"2023","unstructured":"Sweet DG, Carnielli VP, Greisen G, et al.. European consensus guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology. 2023, 120:3-23. 10.1159\/000528914","journal-title":"Neonatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3443","article-title":"Surfactant replacement therapy for preterm and term neonates with respiratory distress","volume":"133","author":"Polin RA","year":"2014","unstructured":"Polin RA, Carlo WA. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014, 133:156-63. 10.1542\/peds.2013-3443","journal-title":"Pediatrics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1267-8","article-title":"Porcine versus bovine surfactant therapy for RDS in preterm neonates: Pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes","volume":"21","author":"Foligno S","year":"2020","unstructured":"Foligno S, De Luca D. Porcine versus bovine surfactant therapy for RDS in preterm neonates: Pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes. Respir Res. 2020, 21:8. 10.1186\/s12931-019-1267-8","journal-title":"Respir Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2018.07185","article-title":"Surfactant preparations for preterm infants with respiratory distress syndrome: Past, present, and future","volume":"62","author":"Jeon GW","year":"2019","unstructured":"Jeon GW. Surfactant preparations for preterm infants with respiratory distress syndrome: Past, present, and future. Korean J Pediatr. 2019, 62:155-61. 10.3345\/kjp.2018.07185","journal-title":"Korean J Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5812\/ijp.5743","article-title":"Comparison of the efficacy of three natural surfactants (Curosurf, Survanta, and Alveofact) in the treatment of respiratory distress syndrome among neonates: A randomized controlled trial","volume":"26","author":"Mussavi M","year":"2016","unstructured":"Mussavi M, Mirnia K, Asadollahi K. Comparison of the efficacy of three natural surfactants (Curosurf, Survanta, and Alveofact) in the treatment of respiratory distress syndrome among neonates: A randomized controlled trial. Iran J Pediatr. 2016, 26:e5743. 10.5812\/ijp.5743","journal-title":"Iran J Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-020-0603-7","article-title":"Beractant and poractant alfa in premature neonates with respiratory distress syndrome: A systematic review of real-world evidence studies and randomized controlled trials","volume":"40","author":"Luna MS","year":"2020","unstructured":"Luna MS, Bacher P, Unnebrink K, Martinez-Tristani M, Navarro CR. Beractant and poractant alfa in premature neonates with respiratory distress syndrome: A systematic review of real-world evidence studies and randomized controlled trials. J Perinatol. 2020, 40:1121-34. 10.1038\/s41372-020-0603-7","journal-title":"J Perinatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-823779","article-title":"A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants","volume":"21","author":"Ramanathan R","year":"2004","unstructured":"Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol. 2004, 21:109-19. 10.1055\/s-2004-823779","journal-title":"Am J Perinatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-022-01346-0","article-title":"Poractant alfa versus bovine lipid extract surfactant: Prospective comparative effectiveness study","volume":"42","author":"Lemyre B","year":"2022","unstructured":"Lemyre B, Lacaze-Masmonteil T, Shah PS, et al.. Poractant alfa versus bovine lipid extract surfactant: Prospective comparative effectiveness study. J Perinatol. 2022, 42:468-75. 10.1038\/s41372-022-01346-0","journal-title":"J Perinatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201812-2348OC","article-title":"The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach","volume":"200","author":"Jensen EA","year":"2019","unstructured":"Jensen EA, Dysart K, Gantz MG, et al.. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019, 200:751-9. 10.1164\/rccm.201812-2348OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm","volume":"92","author":"Papile LA","year":"1978","unstructured":"Papile LA, Burstein J, Burstein R, et al.. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J Pediatr. 1978, 92:529-34. 10.1016\/s0022-3476(78)80282-0","journal-title":"J Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1984.01040030908011","article-title":"An international classification of retinopathy of prematurity","volume":"102","author":"Committee for the Classification of Retinopathy of Prematurity","year":"1984","unstructured":"Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984, 102:1130-4. 10.1001\/archopht.1984.01040030908011","journal-title":"Arch Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197801000-00001","article-title":"Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging","volume":"187","author":"Bell MJ","year":"1978","unstructured":"Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978, 187:1-7. 10.1097\/00000658-197801000-00001","journal-title":"Ann Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13397-1","article-title":"CRIB II: An update of the clinical risk index for babies score","volume":"361","author":"Parry G","year":"2003","unstructured":"Parry G, Tucker J, Tarnow-Mordi W. CRIB II: An update of the clinical risk index for babies score. Lancet. 2003, 361:1789-91. 10.1016\/S0140-6736(03)13397-1","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072779","article-title":"Gestational age at birth and cognitive outcomes in adolescence: Population based full sibling cohort study","volume":"380","author":"Husby A","year":"2023","unstructured":"Husby A, Wohlfahrt J, Melbye M. Gestational age at birth and cognitive outcomes in adolescence: Population based full sibling cohort study. BMJ. 2023, 380:e072779. 10.1136\/bmj-2022-072779","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1209765","article-title":"The impact of small-for-gestational-age Status on the outcomes in very-low-birth-weight (VLBW) premature infants: A prospective cohort study in Taiwan","volume":"11","author":"Lin CY","year":"2023","unstructured":"Lin CY, Chang HY, Chang JH, Hsu CH, Jim WT, Peng CC, Chen CH. The impact of small-for-gestational-age Status on the outcomes in very-low-birth-weight (VLBW) premature infants: A prospective cohort study in Taiwan. Front Pediatr. 2023, 11:1209765. 10.3389\/fped.2023.1209765","journal-title":"Front Pediatr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-017-0921-x","article-title":"Comparing very low birth weight versus very low gestation cohort methods for outcome analysis of high risk preterm infants","volume":"17","author":"Koller-Smith LI","year":"2017","unstructured":"Koller-Smith LI, Shah PS, Ye XY, et al.. Comparing very low birth weight versus very low gestation cohort methods for outcome analysis of high risk preterm infants. BMC Pediatr. 2017, 17:166. 10.1186\/s12887-017-0921-x","journal-title":"BMC Pediatr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286997","article-title":"Comparing the clinical and economic efficiency of four natural surfactants in treating infants with respiratory distress syndrome","volume":"18","author":"Izadi R","year":"2023","unstructured":"Izadi R, Shojaei P, Haqbin A, Habibolahi A, Sadeghi-Moghaddam P. Comparing the clinical and economic efficiency of four natural surfactants in treating infants with respiratory distress syndrome. PLOS ONE. 2023, 18:e0286997. 10.1371\/journal.pone.0286997","journal-title":"PLOS ONE"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1295648","article-title":"A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome","volume":"29","author":"Dizdar EA","year":"2012","unstructured":"Dizdar EA, Sari FN, Aydemir C, Oguz SS, Erdeve O, Uras N, Dilmen U. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome. Am J Perinatol. 2012, 29:95-100. 10.1055\/s-0031-1295648","journal-title":"Am J Perinatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1055\/a-1754-0943","article-title":"Pulmonary complications in premature infants using a Beractant or poractant for respiratory distress syndrome: A retrospective cohort study","volume":"41","author":"Wong KL","year":"2024","unstructured":"Wong KL, Siu KL. Pulmonary complications in premature infants using a Beractant or poractant for respiratory distress syndrome: A retrospective cohort study. Am J Perinatol. 2024, 41:641-8. 10.1055\/a-1754-0943","journal-title":"Am J Perinatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.14734\/PN.2016.27.3.162","article-title":"Early prophylactic use of Curosurf\u00ae versus Newfactan\u00ae for respiratory distress syndrome in premature infants","volume":"27","author":"Na YJ","year":"2016","unstructured":"Na YJ, Lee JH, Park MS. Early prophylactic use of Curosurf\u00ae versus Newfactan\u00ae for respiratory distress syndrome in premature infants. Perinatology. 2016, 27:162-167. 10.14734\/PN.2016.27.3.162","journal-title":"Perinatology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2015.56.2.433","article-title":"Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: A retrospective study","volume":"56","author":"Jeon GW","year":"2015","unstructured":"Jeon GW, Oh M, Sin JB. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: A retrospective study. Yonsei Med J. 2015, 56:433-9. 10.3349\/ymj.2015.56.2.433","journal-title":"Yonsei Med J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02920-9","article-title":"Retrospective comparison of death or neurodevelopmental outcomes in extremely low birth weight preterm infants following different management options of haemodynamically significant patent ductus arteriosus","volume":"21","author":"Wu JJ","year":"2021","unstructured":"Wu JJ, Niduvaje K, Lee LY, Amin Z. Retrospective comparison of death or neurodevelopmental outcomes in extremely low birth weight preterm infants following different management options of haemodynamically significant patent ductus arteriosus. BMC Pediatr. 2021, 21:457. 10.1186\/s12887-021-02920-9","journal-title":"BMC Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4274\/jpr.galenos.2020.04864","article-title":"Comparison of the efficacy of three natural surfactants in preterm Turkish newborns with respiratory distress syndrome","volume":"8","author":"Y\u0131lmaz FH","year":"2021","unstructured":"Y\u0131lmaz FH, Tarak\u00e7\u0131 N, G\u00fcltekin ND. Comparison of the efficacy of three natural surfactants in preterm Turkish newborns with respiratory distress syndrome. J Pediatr Res. 2021, 8:124-130. 10.4274\/jpr.galenos.2020.04864","journal-title":"J Pediatr Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/318411-comparison-of-efficacy-of-beractant-survanta-and-poractant-alfa-curosurf-in-preterm-infants-with-respiratory-distress-syndrome-in-tawam-hospital-al-ain-uae-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T04:15:43Z","timestamp":1732940143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/318411-comparison-of-efficacy-of-beractant-survanta-and-poractant-alfa-curosurf-in-preterm-infants-with-respiratory-distress-syndrome-in-tawam-hospital-al-ain-uae-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.74790","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}